Trials / Completed
CompletedNCT00912847
Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,018 (actual)
- Sponsor
- Chinese University of Hong Kong · Academic / Other
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is: 1. To establish and compare the diagnostic utilities for hepatocellular carcinoma (HCC) screening tests of (a) HS-AFP, (b) AFP + US,(c) AFP alone and (d) US alone (within HBV carriers between age 40 and 70 years); 2. To establish the cost-effectiveness of the screening tests; 3. To compare tumor sizes, resection rates, and survival rates up to 18 months between those who were screened by HS-AFP those of a historical control group that was not screened.
Conditions
Timeline
- Start date
- 1997-10-01
- Primary completion
- 2004-04-01
- Completion
- 2004-04-01
- First posted
- 2009-06-03
- Last updated
- 2009-06-03
Source: ClinicalTrials.gov record NCT00912847. Inclusion in this directory is not an endorsement.